TCT-106 Clinical Outcomes of Percutaneous Coronary Intervention with Nobori, Biolimus A9 Eluting Stent and Everolimus Eluting Stent for High Age Patients
نویسندگان
چکیده
منابع مشابه
Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries
Bernard Chevalier, MD; Sigmund Silber, MD; Seung-Jung Park, MD, PhD; Eulogio Garcia, MD; Gerhard Schuler, MD, PhD; Harry Suryapranata, MD, PhD; Jacques Koolen, MD, PhD; Karl E. Hauptmann, MD; William Wijns, MD, PhD; Marie-Claude Morice, MD; Didier Carrie, MD, PhD; Gerrit-Anne van Es, PhD; Hirofumi Nagai, PhD; Danny Detiege, MS; Dragica Paunovic, MD; Patrick W. Serruys, MD, PhD; for the NOBORI 1...
متن کاملClinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.
BACKGROUNDS The Nobori is a new-generation, biodegradable-polymer coated, biolimus-eluting stent (BES) that has recently been investigated in several randomized trials with inconsistent results. The aim of this study was to assess the efficacy and safety of Nobori BES versus other drug-eluting stents (DES) in patients treated with percutaneous coronary intervention (PCI). METHODS We undertook...
متن کاملIncidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation
BACKGROUND Stent fracture (SF) after drug-eluting stent implantation has become an important concern. The aim of this study was to assess the incidence, predictors, and clinical impact of SF after biolimus-eluting stent. METHODS AND RESULTS A total of 1026 patients with 1407 lesions undergoing the Nobori biolimus-eluting stent implantation and follow-up angiography within 9 months after index...
متن کاملEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
Despite the remarkable benefits obtained following the introduction of the first-generation drug-eluting stent (DES), concerns were raised over its long-term safety, particularly with regard to very late (beyond 1 year) stent thrombosis. Newer-generation DESs have been developed to overcome this limitation using novel stent platforms, new drugs, more biocompatible durable polymers, and bioabsor...
متن کاملone-year outcome of everolimus-eluting stents versus biolimus-eluting stents in patients undergoing percutaneous coronary intervention
background: the biolimus-eluting stent (bes), with a biodegradable polymer, has not been previously compared with the everolimus-eluting stent (ees), as a second-generation drug-eluting stent (des).we sought to compare the 1-year outcome between the promus ™ stent (ees type) and the biomatrix ™ stent (bes type). methods: from march 2008 to september 2011, all patients treated with the promus™ s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2014
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2014.07.135